China
0
No.2 beihuan road shanxian
Add Favorite
Report Supplier
Business Description
Shandong Weigao Group Kanglida Medical Products Co., Ltd. (KLD Medical) is a professional manufacturer, and raw material supplier of in China. Our main products are full of U.S.P sutures covering polyglycolic , PGLA, , plain catgut, silk, nylon, , , suture needle and raw materials, etc. We also provide the and surgical etc. other products under the of Shandong Weigao Group. Our factory was in 1983, we are a company to professionally develop and market surgical suture in China. Our company is registered with a capital RMB8,000,000 and a member of 131. The maximum manufacturing ability is 500,000 pieces surgical sutures every month."KLD Medical" has been making efforts to develop and improve the surgical suture by high-quality products, sound and initial spirit since it was . We have international market brands of "KLD", "KANGLIDA" and "CHUNLE". Today "KLD Medical" has become the medical product manufacturing and exporting base of China. Our customers are around the world, including Asia, the Middle East, Egypt, Germany, Russia, South America and so on. We are willing to do our best for the of international surgical products.
Business Overview
Avg Response Time
≤ 1h
Export Capabilities
Declared by supplierShandong Kanglida Medical Products Co., Ltd. has been exporting since 2002.
Export start year
2002
Trade Capabilities
Business Terms
Trade Ability
Medical Stitching Threads market insight
Across Medical & HealthCare, the wider group Medical Stitching Threads belongs to, Freshdi lists 9 active supply listings from 9 suppliers in 6 countries, as of 20 November 2026. Medical Stitching Threads belongs to Medical & HealthCare, whose suppliers on Freshdi come from 6 countries, led by India at 22.2%, as of 20 November 2026. Buyer inquiry volume across Medical & HealthCare, the wider group Medical Stitching Threads belongs to, rose 100% on Freshdi in the 30 days to 20 November 2026 against the 30 days before, with 103.41% volatility in monthly inquiry and quotation activity over 338 days.
